Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase 1 (Cdk1), formerly called Cdc2 (or p34(Cdc2)), interacts with cyclin B1 to form an active heterodimer. The activity of Cdk1 is subjected to a complex spatiotemporary regulation, required to guarantee its scheduled contribution to the mitotic prophase and metaphase. Moreover, the activation of Cdk1 may be required for apoptosis induction in some particular pathways of cell killing. This applies to several clinically important settings, for instance to paclitaxel-induced killing of breast cancer cells, in which the ErbB2 receptor kinase can mediate apoptosis inhibition through inactivation of Cdk1. The activation of Cdk1 participates also in HIV-1-induced apoptosis, upstream of the p53-dependent mitochondrial permeabilization step. An unscheduled Cdk1 activation may contribute to neuronal apoptosis occurring in neurodegenerative diseases. Finally, the premature activation of Cdk1 can lead to mitotic catastrophe, for instance after irradiation-induced DNA damage. Thus, a cell type-specific modulation of Cdk1 might be taken advantage of for the therapeutic correction of pathogenic imbalances in apoptosis control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the primary alterations that drive catastrophic mitoses can originate in other phases of the cell cycles, including the S phase (e.g., a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [979]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“As shown in a phase II clinical trial, such cancers become responsive to taxol in vivo when taxol is combined with Herceptin (Trastuzumab), a humanized monoclonal anti-ErbB2 antibody.(24) In HL60 myelomonocytic leukemia cells, the taxolinduced Cdk1 activation is not affected by Bcl-2 nor is it inhibited by the pan-cas…”
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Self-citationMitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Organelle-specific initiation of cell death pathways
Ferri, K. F., & Kroemer, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-e255 · Cited by 1,456
Self-citationYamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., & Landau, N. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6705-6711.1995 · Cited by 904
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Freeman, R. S., Estus, S., & Johnson, E. M. (1994) · Neuron · doi:10.1016/0896-6273(94)90276-3 · Cited by 573
Research works printed but not linked: 1
- Zhai S, Senderowicz AM, Sausville EA, Figg WD . 2002 Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development Ann. Pharmacother. 36: 905–911 · doi:10.1345/aph.1a162 · Paper page
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
“, a premature entry in mitosis caused by failure of the intra-S-phase checkpoint) [979, 980].”
BackgroundSelf-citationCell death by mitotic catastrophe: a molecular definition
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207528 · Cited by 1,269
“…or genetic manipulations, for instance, in human colorectal adenocarcinoma cell lines treated with fluorouracil (Yoshikawa et al., 2001), 14-3-3s / colon cancer cells treated with doxorubicin (Chan et al., 1999), as well as in heterokarya induced by cell fusion (Castedo et al., 2001, 2002b).”
BackgroundSelf-citationPathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
YAP/TAZ Signaling and Resistance to Cancer Therapy
Nguyen, C. D. K., & Yi, C. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.02.010 · Cited by 437
“Conversely, Cyclin-dependent kinase 1 (CDK1), sensitizes ovarian cancer cells to taxanes by phosphorylating LATS1/2 and YAP/TAZ [75,78,80,84,86,87].”
BackgroundTrial watch: IDO inhibitors in cancer therapy
Vacchelli, E., Aranda, F., Eggermont, A., Sautès-Fridman, C., Tartour, E., Kennedy, E. P., Platten, M., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.957994 · Cited by 326
Self-citationVennin, C., Chin, V. T., Warren, S. C., Lucas, M. C., Herrmann, D., Magenau, A., Melenec, P., Walters, S. N., del Monte-Nieto, G., Conway, J. R. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8504 · Cited by 267
Vital functions for lethal caspases
Launay, S., Hermine, O., Fontenay, M., Kroemer, G., Solary, E., & Garrido, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208524 · Cited by 226
Self-citationTerrano, D. T., Upreti, M., & Chambers, T. C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-09 · Cited by 215
Swift, L., & Golsteyn, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033403 · Cited by 213
Non-apoptotic functions of caspases in cellular proliferation and differentiation
Schwerk, C., & Schulze-Osthoff, K. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00497-0 · Cited by 200
Trial watch: IDO inhibitors in cancer therapy
Le Naour, J., Galluzzi, L., Zitvogel, L., Kroemer, G., & Vacchelli, E. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1777625 · Cited by 187
Self-citationGérard, C., & Goldbeter, A. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0075 · Cited by 183
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe
Castedo, M., Perfettini, J.-L., Roumier, T., Yakushijin, K., Horne, D., Medema, R., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207573 · Cited by 175
Self-citationMechanisms of apoptosis induction by the HIV-1 envelope
Perfettini, J.-L., Castedo, M., Roumier, T., Andreau, K., Nardacci, R., Piacentini, M., & Kroemer, G. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401584 · Cited by 169
Self-citationYang, J.-H., Hsia, T.-C., Kuo, H.-M., Chao, P.-D. L., Chou, C.-C., Wei, Y.-H., & Chung, J.-G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005280 · Cited by 165
Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis
Amith, S. R., & Fliegel, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4031 · Cited by 153
Silibinin Efficacy against Human Hepatocellular Carcinoma
Varghese, L., Agarwal, C., Tyagi, A., Singh, R. P., & Agarwal, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1646 · Cited by 146
Li, M., You, L., Xue, J., & Lu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00522 · Cited by 137
G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression
Collins, N. L., Reginato, M. J., Paulus, J. K., Sgroi, D. C., LaBaer, J., & Brugge, J. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5282-5291.2005 · Cited by 136
A link between mitotic defects and mitotic catastrophe: detection and cell fate
Sazonova, E. V., Petrichuk, S. V., Kopeina, G. S., & Zhivotovsky, B. (2021) · Biology Direct · doi:10.1186/s13062-021-00313-7 · Cited by 155
Byth, K. F., Thomas, A., Hughes, G., Forder, C., McGregor, A., Geh, C., Oakes, S., Green, C., Walker, M., Newcombe, N., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0836 · Cited by 121
Yun, J., Kweon, M., Kwon, H., Hwang, J., & Mukhtar, H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi348 · Cited by 137
Sung, W., Lin, Y., Wu, P., Yen, H., Lai, H., Su, T., Huang, R.-H., Wen, C.-K., Chen, C., Chen, C., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-951 · Cited by 130
Perfettini, J., Roumier, T., Castedo, M., Larochette, N., Boya, P., Raynal, B., Lazar, V., Ciccosanti, F., Nardacci, R., Penninger, J. M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031216 · Cited by 140
Self-citationThe multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 120
Yang, J., Chen, G.-W., Hsia, T., Ho, H.-C., Ho, C.-C., Lin, M.-W., Lin, S., Yeh, R.-D., Ip, S., Lu, H. F., et al. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.10.032 · Cited by 120
Apoptosis-like yeast cell death in response to DNA damage and replication defects
Burhans, W. C., Weinberger, M., Marchetti, M. A., Ramachandran, L., D’Urso, G., & Huberman, J. A. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.019 · Cited by 116
Intracellular Clusterin Induces G2-M Phase Arrest and Cell Death in PC-3 Prostate Cancer Cells1
Scaltriti, M., Santamaria, A., Paciucci, R., & Bettuzzi, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0920 · Cited by 104
Shang, Z.-F., Huang, B., Xu, Q.-Z., Zhang, S.-M., Fan, R., Liu, X.-D., Wang, Y., & Zhou, P.-K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3362 · Cited by 102
Sabbaghi, M., Gil-Gómez, G., Guardia, C., Servitja, S., Arpí, O., García-Alonso, S., Menendez, S., Arumi-Uria, M., Serrano, L., Salido, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0696 · Cited by 102
Whitehead, A., Roach, J. L., Zhang, S., & Gálvez-Montosa, F. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.062075 · Cited by 105
Kim, S. J., Nakayama, S., Miyoshi, Y., Taguchi, T., Tamaki, Y., Matsushima, T., Torikoshi, Y., Tanaka, S., Yoshida, T., Ishihara, H., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm358 · Cited by 101
Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells
Cho, H. J., & Park, J. H. Y. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.3.257 · Cited by 100
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
Kalimutho, M., Sinha, D., Jeffery, J., Nones, K., Srihari, S., Fernando, W., Duijf, P. H. G., Vennin, C., Raninga, P. V., Nanayakkara, D. M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708566 · Cited by 113
Khazaei, S., Esa, N. M., Ramachandran, V., Hamid, R. A., Pandurangan, A. K., Etemad, A., & Ismail, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00005 · Cited by 97
How Many Ways Can a Podocyte Die?
Tharaux, P., & Huber, T. B. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.06.011 · Cited by 99
Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.037 · Cited by 100
Petsalaki, E., & Zachos, G. (2020) · FEBS Journal · doi:10.1111/febs.15240 · Cited by 103
Reasons to reconsider the significance of apoptosis for cancer therapy
Abend, M. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001632958 · Cited by 91
γ-Secretase Inhibitors Enhance Taxane-Induced Mitotic Arrest and Apoptosis in Colon Cancer Cells
Akiyoshi, T., Nakamura, M., Yanai, K., Nagai, S., Wada, J., Koga, K., Nakashima, H., Sato, N., Tanaka, M., & Katano, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.008 · Cited by 89
Apoptosis in budding yeast caused by defects in initiation of DNA replication
Weinberger, M., Ramachandran, L., Li, F., Sharma, K., Sun, X., Marchetti, M. A., Huberman, J. A., & Burhans, W. C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02477 · Cited by 89
Fukuda, S., Mantel, C., & Pelus, L. M. (2003) · Blood · doi:10.1182/blood-2003-05-1756 · Cited by 94
Survivin and escaping in therapy‐induced cellular senescence
Wang, Q. L., Wu, P., Roberson, R. S., Luk, B. V., Ivanova, I., Chu, E., & Wu, D. Y. (2010) · International Journal of Cancer · doi:10.1002/ijc.25482 · Cited by 95
Røe, O. D., Anderssen, E., Helge, E., Pettersen, C. H., Olsen, K. S., Sandeck, H., Haaverstad, R., Lundgren, S., & Larsson, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006554 · Cited by 82
Chang, K.-H., Vincent, F., & Shah, K. (2012) · Journal of Cell Science · doi:10.1242/jcs.108183 · Cited by 82
Dütting, S., Brachs, S., & Mielenz, D. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-2 · Cited by 86
Jiang, H., Luo, S., & Li, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413431200 · Cited by 81
Diverse system stresses: common mechanisms of chromosome fragmentation
Stevens, J. B., Abdallah, B. Y., Liu, G., Ye, C. J., Horne, S. D., Wang, G., Savaşan, S., Shekhar, M. P. V., Krawetz, S. A., Hüttemann, M., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.60 · Cited by 85
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinic
Shi, J., & Mitchison, T. J. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0003 · Cited by 79
Li, C., & Elsasser, T. H. (2005) · Journal of Animal Science · doi:10.2527/2005.83189x · Cited by 87
Rajput, S., Khera, N., Guo, Z., Hoog, J., Li, S., & Ma, C. X. (2016) · Oncotarget · doi:10.18632/oncotarget.10870 · Cited by 81
From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
Young, A. M. H., Chakrabarti, B., Roberts, D., Lai, M.-C., Suckling, J., & Baron-Cohen, S. (2016) · Molecular Autism · doi:10.1186/s13229-016-0068-x · Cited by 76
Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies
Vakili‐Samiani, S., Jalil, A. T., Abdelbasset, W. K., Yumashev, A. V., Karpisheh, V., Jalali, P., Adibfar, S., Ahmadi, M., Feizi, A. A. H., & Jadidi‐Niaragh, F. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103203 · Cited by 76
Kinase Inhibitors from Marine Sponges
Skropeta, D., Pastro, N. J., & Zivanovic, A. (2011) · Marine Drugs · doi:10.3390/md9102131 · Cited by 76
Kim, S., Jang, J. Y., Kim, E., Cho, E. K., Ahn, D., Kim, C., Park, H. S., Jeong, S. W., Lee, S. H., Kim, S. G., et al. (2017) · Hepatology · doi:10.1002/hep.29177 · Cited by 72
Lei, Q., Xiong, L., Xia, Y., Feng, Z., Gao, T., Wei, W., Song, X., Ye, T., Wang, N., Peng, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1071-2 · Cited by 75
Prazosin Displays Anticancer Activity against Human Prostate Cancers: Targeting DNA, Cell Cycle
Lin, S.-C., Chueh, S., Hsiao, C., Li, T., Chen, T., Liao, C.-H., Lyu, P. C., & Guh, J. (2007) · Neoplasia · doi:10.1593/neo.07475 · Cited by 75
Rubner, Y., Muth, C., Strnad, A. R., Derer, A., Sieber, R., Buslei, R., Frey, B., Fietkau, R., & Gaipl, U. S. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-89 · Cited by 76
Santoro, A., Pisanti, S., Grimaldi, C., Izzo, A. A., Borrelli, F., Proto, M., Malfitano, A. M., Gazzerro, P., Laezza, C., & Bifulco, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24483 · Cited by 74
Oxidative stress‐induced death in the nervous system: Cell cycle dependent or independent?
Langley, B., & Ratan, R. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20210 · Cited by 70
Rivera, A. M., Mavila, A., Bayless, K. J., Davis, G. E., & Maxwell, S. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-5521-5 · Cited by 72
Chen, C., Liao, C.-H., Chang, Y.-L., Guh, J., Pan, S., & Teng, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.042 · Cited by 68
Zhou, L., Chan, W. K. B., Xu, N., Xiao, K., Luo, H.-W., Luo, K. Q., & Chang, D. C. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.011 · Cited by 68
Role of autophagy in HIV infection and pathogenesis
Nardacci, R., Ciccosanti, F., Marsella, C., Ippolito, G., Piacentini, M., & Fimia, G. M. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12596 · Cited by 76
p53: 25 years of research and more questions to answer
Bourdon, J., Laurenzi, V. D., Melino, G., & Lane, D. P. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401243 · Cited by 76
Virus manipulation of cell cycle
Nascimento, R., Costa, H., & Parkhouse, R. M. E. (2011) · PROTOPLASMA · doi:10.1007/s00709-011-0327-9 · Cited by 70
Chen, Y.-C., Lu, P., Pan, S., Teng, C., Kuo, S., Lin, T. P., Ho, Y., Huang, Y.-C., & Guh, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.03.015 · Cited by 64
Kedinger, V., Meulle, A., Zounib, O., Bonnet, M.-E., Gossart, J.-B., Benoit, E., Messmer, M., Shankaranarayanan, P., Behr, J., Erbacher, P., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-338 · Cited by 63
Anbalagan, M., Carrier, L., Glodowski, S., Hangauer, D. G., Shan, B., & Rowan, B. G. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1513-3 · Cited by 62
Raghavan, P., Tumati, V., Yu, L., Chan, N. H. L., Tomimatsu, N., Burma, S., Bristow, R. G., & Saha, D. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.05.035 · Cited by 60
Schaefer, K. L., Takahashi, H., Morales, V. M., Harris, G., Barton, S., Osawa, E., Nakajima, A., & Saubermann, L. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22361 · Cited by 61
Naidu, S., Shi, L., Magee, P., Middleton, J. D., Laganà, A., Sahoo, S., Leong, H. S., Galvin, M., Frese, K. K., Dive, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14843-6 · Cited by 60
Lü, J., Chen, X. '., Qu, S., Yao, B., Xu, Y., Wu, J., Jin, Y., & Ma, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.5751 · Cited by 60
Clavaminols A–F, novel cytotoxic 2-amino-3-alkanols from the ascidian Clavelina phlegraea
Aiello, A., Fattorusso, E., Giordano, A., Menna, M., Navarrete, C. M., & Muñóz, E. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.015 · Cited by 58
Vidyasekar, P., Shyamsunder, P., Arun, R. P., Santhakumar, R., Kapadia, N. K., Kumar, R., & Verma, R. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135958 · Cited by 62
Zhang, C., ELKAHLOUN, A. G., Robertson, M., Gills, J. J., Tsurutani, J., Shih, J. H., Fukuoka, J., Hollander, M. C., Harris, C. C., Travis, W. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023849 · Cited by 57
Nag, D., Bhanja, P., Riha, R., Sánchez-Guerrero, G., Kimler, B. F., Tsue, T. T., Lominska, C. E., & Saha, S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2751 · Cited by 59
Kroczek, C., Lang, C., Brachs, S., Grohmann, M., Dütting, S., Schweizer, A., Nitschke, L., Feller, S. M., Jäck, H.-M., & Mielenz, D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903642 · Cited by 55
Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation
Stevens, J. B., Abdallah, B. Y., Regan, S. M., Liu, G., Bremer, S. W., Ye, C. J., & Heng, H. H. (2010) · Molecular Cytogenetics · doi:10.1186/1755-8166-3-20 · Cited by 58
Perez‐Stable, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.018 · Cited by 55
Meng, X., Yuan, Y., Maestas, A., & Shen, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306794200 · Cited by 59
Weisberg, E., Nonami, A., Chen, Z., Liu, F., Zhang, J., Sattler, M., Nelson, E. A., Cowens, K. B., Christie, A. L., Mitsiades, C. S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.149 · Cited by 54
Gan, F.-F., Nagle, A. A., Ang, X., Ho, O. H., Tan, S.-H., Yang, H., Chui, W., & Chew, E. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0611-3 · Cited by 55
The prognostic value of Cyclin B1 in pancreatic cancer
Zhou, L., Li, J., Zhao, Y.-P., Cui, Q., Zhou, W., Guo, J., You, L., Wu, W., & Zhang, T. (2014) · Medical Oncology · doi:10.1007/s12032-014-0107-4 · Cited by 54
Arshad, N., & Farooqi, S. I. (2018) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-018-2818-z · Cited by 53
CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence
Hongo, F., Takaha, N., Oishi, M., Ueda, T., Nakamura, T., Naitoh, Y., Naya, Y., Kamoi, K., Okihara, K., Matsushima, T., et al. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.05.006 · Cited by 51
Sinha, S., Shukla, S., Khan, S. U., Tollefsbol, T. O., & Meeran, S. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.020 · Cited by 51
Lv, P., Wang, Y., Ma, J., Wang, Z., Li, J.-L., Hong, C. S., Zhuang, Z., & Zeng, Y.-X. (2014) · Oncotarget · doi:10.18632/oncotarget.2258 · Cited by 52
RetractedMarchetti, M. A., Weinberger, M., Murakami, Y., Burhans, W. C., & Huberman, J. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02703 · Cited by 51
Li, L., Gu, B., Zhou, F., Chi, J., Wang, F., Peng, G., Xie, F., Qing, J., Feng, D., Lu, S., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02577-10 · Cited by 49
Byth, K. F., Geh, C., Forder, C. L., Oakes, S. E., & Thomas, A. P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0205 · Cited by 48
A Critical Role of TET1/2 Proteins in Cell-Cycle Progression of Trophoblast Stem Cells
Chrysanthou, S., Senner, C. E., Woods, L., Fineberg, E., Okkenhaug, H., Burge, S., Perez-Garcia, V., & Hemberger, M. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.014 · Cited by 48
Inositol 1,4,5‐trisphosphate receptor (type 1) phosphorylation and modulation by Cdc2
Malathi, K., Kohyama, S., Ho, M., Soghoian, D. Z., Li, X., Silane, M. F., Berenstein, A., & Jayaraman, T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10720 · Cited by 48
Linton, A., Cheng, Y. Y., Griggs, K. M., Kirschner, M. B., Gattani, S., Srikaran, S., Kao, S., McCaughan, B. C., Klebe, S., van Zandwijk, N., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.731 · Cited by 49
Tumour-suppression function of KLF12 through regulation of anoikis
Godin-Heymann, N., Brabetz, S., Murillo, M. M., Saponaro, M., Santos, C. R., Lobley, A., East, P., Chakravarty, P., Matthews, N., Kelly, G. P., et al. (2015) · Oncogene · doi:10.1038/onc.2015.394 · Cited by 50
Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death
Martins, I., Raza, S. Q., Voisin, L., Dakhli, H., Allouch, A., Law, F., Sabino, D., de Jong, D., Thoreau, M., Mintet, E., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0747-y · Cited by 55
Self-citationKojima, K., Shimanuki, M., Shikami, M., Andreeff, M., & Nakakuma, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01150.x · Cited by 55
Bilyk, K. T., & Cheng, C. ‐. C. (2014) · Marine Genomics · doi:10.1016/j.margen.2014.06.006 · Cited by 53
S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism
Kumar, A., Oskouian, B., Fyrst, H., Zhang, M., Paris, F., & Saba, J. D. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.3 · Cited by 45
STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells
Newman, S. P., Foster, P., Stengel, C., Day, J. M., Ho, Y. T., Judde, J., Lassalle, M., Prevost, G. P., Leese, M. P., Potter, B. V. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1717 · Cited by 45
Metadata
- Authors
- Castedo, M., Perfettini, J.-L., Roumier, T., & Kroemer, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Kroemer, G
- Venue
- Cell Death & Differentiation
- Published
- 2002-12
- Volume
- 9
- Issue
- 12
- Pages
- 1287-1293
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2084337297
- Cited by
- 345
- References
- 66
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 14 · 2022: 15 · 2021: 18 · 2020: 11 · 2019: 15 · 2018: 24 · 2017: 17 · 2016: 14 · 2015: 12 · 2014: 23 · 2013: 13 · 2012: 14
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sidaction
- European Commission
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclin-dependent kinase 1, CDK1, apoptosis, mitotic catastrophe, cell cycle regulation, cyclin B1, CDK1 activation, breast cancer, ERBB2, p53, mitochondrial membrane permeabilization, neuronal apoptosis, neurodegenerative diseases, CDK1 inhibition
- MeSH terms
- Animals, DNA Damage, Eukaryotic Cells, Humans, Mitosis, HIV-1, CDC2 Protein Kinase, Apoptosis, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.